RxDoctor Payments Data

Harry Aslanian, MD

Gastroenterology · New Haven, CTNPI 1295718401

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $37,065 of the $52,150 with a category attached, or 71.1%. Boston Scientific accounts for 79.1% of it on its own, with 12 other manufacturers making up the rest. Among gastroenterology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$52,150in general payments, 2019–2025

Across 93 payments — averaging $560.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$41K
  • Olympus Corporation Of The Americas$4K
  • Gyrus ACMI, Inc.$3K
  • Olympus Medical Systems Corporation$670
  • Conmed Corporation$656
  • Covidien LP$543
  • plus $2K from 7 others

What the payments were for

  • Consulting fees$9,48518%
  • Speaking & faculty fees$37,06571%
  • Travel & lodging$1,2272%
  • Food & beverage$4,3238%
  • Entertainment$500%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,150 in reported general payments places this provider in the 90th percentile of 326 gastroenterology providers in Connecticut.

See all gastroenterology providers in Connecticut

Medicare billing

Part B allowed, 2024
$47,038
Medicare patients
159
Services billed
309

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole42$1,179
Ursodiol14$846
Sucralfate22$606
Famotidine26$379
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl14$190

Paid to pharmacies, not to this prescriber.

Other gastroenterology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →